DK1197207T3 - Stabile sammensætninger til parenteral indgivelse - Google Patents

Stabile sammensætninger til parenteral indgivelse

Info

Publication number
DK1197207T3
DK1197207T3 DK01308284T DK01308284T DK1197207T3 DK 1197207 T3 DK1197207 T3 DK 1197207T3 DK 01308284 T DK01308284 T DK 01308284T DK 01308284 T DK01308284 T DK 01308284T DK 1197207 T3 DK1197207 T3 DK 1197207T3
Authority
DK
Denmark
Prior art keywords
compounds
parenteral administration
lambda
warm
alpha
Prior art date
Application number
DK01308284T
Other languages
Danish (da)
English (en)
Inventor
William David Steber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1197207T3 publication Critical patent/DK1197207T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK01308284T 2000-10-10 2001-09-28 Stabile sammensætninger til parenteral indgivelse DK1197207T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23892500P 2000-10-10 2000-10-10

Publications (1)

Publication Number Publication Date
DK1197207T3 true DK1197207T3 (da) 2008-08-04

Family

ID=22899893

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01308284T DK1197207T3 (da) 2000-10-10 2001-09-28 Stabile sammensætninger til parenteral indgivelse

Country Status (9)

Country Link
EP (1) EP1197207B1 (de)
JP (1) JP4221170B2 (de)
AT (1) ATE392887T1 (de)
CA (1) CA2358361C (de)
CY (1) CY1108145T1 (de)
DE (1) DE60133706T2 (de)
DK (1) DK1197207T3 (de)
ES (1) ES2304371T3 (de)
PT (1) PT1197207E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
FR2913884A1 (fr) * 2007-03-21 2008-09-26 Oralance Pharma Sa Systeme galenique hydrophobe non ionisable
ITUB20153652A1 (it) 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici
KR102101969B1 (ko) * 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
MX2021013429A (es) 2019-05-03 2021-12-10 Intervet Int Bv Composiciones farmaceuticas inyectables y usos de las mismas.
PT4153133T (pt) 2020-05-20 2024-01-12 Intervet Int Bv Composições farmacêuticas injetáveis e utilizações das mesmas
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
ES2086022T3 (es) * 1991-07-23 1996-06-16 American Cyanamid Co Composiciones estables para administracion parenteral y su uso.
GB2310801A (en) * 1996-03-04 1997-09-10 Merck & Co Inc Process for removing an organic solvent from lactide-glycoside copolymer microspheres

Also Published As

Publication number Publication date
CA2358361C (en) 2009-08-11
EP1197207B1 (de) 2008-04-23
JP2002161033A (ja) 2002-06-04
AU784023B2 (en) 2006-01-19
DE60133706T2 (de) 2009-07-02
ATE392887T1 (de) 2008-05-15
ES2304371T3 (es) 2008-10-16
CA2358361A1 (en) 2002-04-10
CY1108145T1 (el) 2013-03-13
DE60133706D1 (de) 2008-06-05
PT1197207E (pt) 2008-07-01
EP1197207A3 (de) 2003-02-05
JP4221170B2 (ja) 2009-02-12
EP1197207A2 (de) 2002-04-17
AU7827301A (en) 2002-04-11

Similar Documents

Publication Publication Date Title
DK0525307T3 (da) Stabile præparater til parenteral indgivelse og deres anvendelse
CY1108145T1 (el) Σταθερες συνθεσεις για παρεντερικη χορηγηση
DK1087960T3 (da) Makrocykliske analoger og fremgangsmåder til deres anvendelse og fremstilling
DK0388019T3 (da) Avermectin-ketal-derivater, der er egnede som antiparasitiske midler
DK0810823T3 (da) Sammensætning til bekæmpelse af parasitter
DK1320526T3 (da) Farmaceutisk aktive benzsulfonamidderivater som inhibitorer af protein-junkinaser
PL378024A1 (pl) Pochodne monosacharydowe awermektyny o właściwościach pescytydowych
DK1383756T3 (da) Cumarinderivater til anvendelse som antikoagulanter
AP2004003106A0 (en) Synergistic insecticidal mixtures.
DK0930077T3 (da) Cyclodextrinpræparater indeholdende et avermectin- eller milbemycinderivat
DK1066854T3 (da) Anthelmintiske kompositioner indeholdende kombinationer af avermectiner eller milbemyciner med bis-aryl forbindelser
DE69331007D1 (de) Difluoroavermectin-derivate
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
BR0109891A (pt) Composição farmaceutica contendo derivado de camptotecina e substância de ajuste de ph
ES2080175T3 (es) Estabilizador para una preparacion que contiene 4-etil-2-hidroxiimino-5-nitro-3-hexenamida y metodo de estabilizacion correspondiente.
WO2005027903A8 (en) Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning
WO2004072037A8 (en) 2,3'-bipyridines derivatives as selective cox-2 inhibitors